Green tea: Clinical Trials

6 trials of Green tea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated, 1 unknown. 6 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 3, Terminated 2, Unknown 1
Phase 11Unknown 1
Phase 31Completed 1

Follow Green tea: new trials by email Literature Review of Green tea trials Research Report on Green tea

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dietary Antioxidants, Redox Tone and Health Promotion: an Orthomolecular Study of Interactions
Green tea - Type 2 Diabetes Mellitus
Phase 1 / Phase 2UnknownThe Hong Kong Polytechnic University602011-02-012011-03-16
Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases
Green tea, FPP - Assess the Effect of Green Tea on Diabetes, Assess the Effect of Fermented Papaya Pretration on Diabetes
Phase 2 / Phase 3CompletedThe Touro College and University System3002010-11-012014-11-17
A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
Polyphenon E - Ductal Carcinoma in Situ
Phase 2TerminatedUniversity of Chicago202010-05-012020-04-09
Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease
green tea, Polyphenon E, placebo - Lung Cancer Prevention
Phase 2CompletedSherry Chow1782004-05-012013-11-28
High Tea Consumption on Smoking Related Oxidative Stress
Green tea, Black tea, Placebo tea - Lung Cancer Prevention
Phase 2CompletedUniversity of Arizona1542003-09-012016-03-25
Green Tea and Ultraviolet Light-induced Skin Damage
Green Tea, Placebo - Healthy
Phase 2TerminatedRutgers, The State University of New Jersey682003-05-012017-09-06

Conditions studied

Carcinoma, Intraductal, Noninfiltrating (1)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Lung Neoplasms (1)  ·  Plaque, Atherosclerotic (1)  ·  Smoking Cessation (1)

Sponsors

Rutgers, The State University of New Jersey (1)  ·  Sherry Chow (1)  ·  The Hong Kong Polytechnic University (1)  ·  The Touro College and University System (1)  ·  University of Arizona (1)  ·  University of Chicago (1)

Countries

United States (4)  ·  Austria (1)  ·  China (1)  ·  Mauritius (1)

Top investigators

Iman Hakim, MD, PhD, MPH (1)  ·  Melissa Magliocco, MD (1)  ·  Nora Jaskowiak, MD (1)  ·  Okezie I Aruoma, PhD DSc (1)

Results publications

PMID 22198621, PMID 22330753, PMID 24102055, PMID 24316314, PMID 24769427

NIH funding

P30CA023074 (1), U01CA101204 (1)